By Marie E. Lamont Has anyone in your family had to cancel a doctor’s appointment or hospital visit in recent months? The answer is likely to be yes. Many medical facilities suspended services for all but acute patients due to the COVID-19 crisis. These have been...
News
Category
NIAID Brands Lilly Monoclonal Antibody Trial (ACTIV-2) as ‘RiseAboveCOVID’ & Supported by Great Lakes Clinical Trials in Midwest
A trial site organization known as Great Lakes Clinical Trials now offers the Eli Lilly advanced monoclonal antibody product called LY-CoV555 ( LY3819253), which was recently authorized for emergency use authorization. Known now as bamlanivimab, Great Lakes Clinical...
CCT Research Expands Research as Care Option Embedding Research in Salt Lake City-based Community Health Centers
CCT Research, a leader in community-based, embedded clinical research, today announced the expansion of its clinical trial operations to the Salt Lake City metropolitan area. CCT will partner with Olympus Family Medicine, Ogden Clinic and Springville Dermatology,...
Germany Initiates ‘Side Deals’ for COVID-19 Vaccine As Emergency Authorization is Imminent in Both the U.S. & Europe
Apparently, access to COVID-19 vaccine product, with imminent regulatory authorization, isn’t sufficient for Germany as Europe’s economic engine isn’t satisfied with the allocation awarded as part of the European Union plan. Rather, Jens Spahn, Health Minister, along...
Intermountain Healthcare Investigates Anti-Thrombotic Strategies in COVID-19 Adults Not Needing Hospitalization
Over the summer, the University of Utah concluded a study indicating that COVID-19 influenced change in blood platelets may spur heart attacks, strokes, and other serious cardiovascular complications. Now Intermountain Healthcare, one of the nation’s leading...
Manitobans Split on Whether to Get in the COVID-19 Vaccination Line
With the United Kingdom’s recent regulatory approval of the COVID-19 vaccine developed by Pfizer and BioNTech and imminent emergency use authorization expected in America for that same vaccine, Health Canada is also close to a greenlight call this month. Highest on...
Palm Beach Research Center Treats First Participant in AstraZeneca Convalescent-based Monoclonal Antibody Clinical Trial
Palm Beach Research Center, a Florida-based trial site organization, treated the first participant in a new AstraZeneca clinical trial investigating an monoclonal antibody combination treatment targeting COVID-19. Known as AZD7442, this investigational product is a...
MIT Lincoln Laboratory Drive Investigation into the Benefits of Remote Patient Monitoring During COVID-19 Pandemic
MIT’s Lincoln Laboratory led a 60-person task force to review mobile health (mHealth) technologies as useful for monitoring and mitigating impacts associated with the COVID-19 pandemic. The conclusion: mHealth technologies are in fact viable options to help medical...
IQVIA Building Remote COVID-19 Vaccine Safety Monitoring Operation in Ireland Creating 170 Jobs
The world’s largest combined contract research organization (CRO) and biomedical research information services company, IQVIA will form 170 new remote jobs in Ireland as the CRO establishes a COVID-19 vaccine safety monitoring unit in that nation. Targeting...
Utah COVID-19 Long Haulers Group & University of Utah Raising Funds to Kick off Medical Research
Those who fall ill to COVID-19 and don’t fully recover are known as “Long Haulers,” and there is a growing number of them in TrialSite’s home state of Utah. Recently showcased on KSLTV, a growing number of patients, such as Lisa O’Brien, report that a continuous...
‘Generic Drug Repurposing for COVID-19” The Israeli Perspective’
Tel Aviv University’s Spark program recently hosted a webinar titled “Generic Drug Repurposing for COVID-19: The Israeli Perspective.” In collaboration with the MedInsight Institute, presenters included Professor Alex Jadad, Faculty of Medicine and School of Public...
Pakistan Procures 10.6m Doses of Ad5-nCoV for $14 Per Dose but Seeks to Diversify with Other Vaccine Makers
CanSino Biologics, one of China’s leading vaccine makers, inked a deal with Pakistan’s government to sell the Ad5-nCoV vaccine candidate to that nation selling 10,600,000 vaccine doses (5% of the 212m population) for $150 million, equaling a price point of...
Judith Montero, PsyD, Joins CenExel Clinical Research as Director of Clinical Assessments
CenExel Clinical Research (“CenExel”) announced that Judith Montero, PsyD, has joined CenExel as Director of Clinical Assessments. Dr. Montero will work closely with rater personnel at all CenExel Centers of Excellence to ensure the highest quality of ratings scales...
State of Virginia Conducts Pfizer/BioNTech COVID-19 Vaccine Test Run with Inova Health
Virginia state epidemiologist Lilian Peake informed legislators this week that the Virginia Department of Health was in the process of collaborating with regional health system Inova in the execution of an “end-to-end test” to assess the state’s readiness for...
Great Plains Health Severe COVID-19 Patients Benefit from RLF-100
Recently showcased on local media, North Platte Nebraska’s Great Plains Health (GPH) has treated at least 20 patients with Aviptadil (RLF-100), an investigational product recently submitted for emergency use authorization in late September. One of those surviving...
Fourth Iteration of COVID-19 Treatment Trial Underway
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced that the fourth iteration of the Adaptive COVID-19 Treatment Trial (ACTT-4) has begun to enroll hospitalized adults with coronavirus disease...
Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine (BNT162b2), against...
Novavax Announces COVID-19 Vaccine Clinical Development Progress
Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its COVID-19 vaccine program. NVX‑CoV2373 is a stable, prefusion protein antigen derived from the genetic...
NIH Announces Restructured HIV Clinical Trials Networks
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced the clinical investigators and institutions that will lead four NIH HIV clinical trials networks over the next seven years to conduct the...
Coronavirus Was In U.S. Weeks Earlier Than Previously Known, Study Says
As reported by NPR, the coronavirus was present in the U.S. weeks earlier than scientists and public health officials previously thought, and before cases in China were publicly identified, according to a new government study published Monday. The virus and the...